Category Archives: Diabetes

My mother had Type 2 diabetes. While she was living with and going through that, I didn't know about the strong connection between Type 2 diabetes and heart disease; I just worked to try to make her comfortable and manage the day to day. Perhaps if I had known that people living with diabetes are twice as likely to develop and die from cardiovascular disease, we could have asked her doctor different questions and been more diligent in helping her manage the risk to the complication that would eventually claim her life.

My mother made her transitionbecause of heart failure resulting from her Type 2 diabetes.

She was a woman who truly cared about people in her community. When I wasn't around, my mother spent time with all kinds of folks she had met especially young people she adored. When she passed, so many individuals she had met wrote me cards. I had no idea that she really spoke to them and brought so much into their lives. She was a simple and hard-working woman. She never made a lot of money, but she had an impact on the lives of those she met.

Get the think newsletter.

I decided that trying to help my mother continue making an impact on people's lives was a way I could honor her. That was why I teamed up with the American Diabetes Association and the American Heart Association to get the message out about the connection between Type 2 diabetes, heart disease and stroke. We are trying to help people like my mother.

For many people, when you hear news that's overwhelming like a diagnosis of diabetes you have one of two reactions: You either feel like your feet are being held to the fire and decide, Let's get moving, let's do something about this; or it's like, Oh my God, it's just all too much for me. The collaboration between the American Heart Association and the American Diabetes Association, called Know Diabetes by Heart, helps those people who are newly diagnosed with Type 2 diabetes (and their loved ones and family members) break down what to do next into bite-size portions, to get a handle on what it all means, so they can manage it and stay in the know.

One important thing we are trying to do is help people have conversations with their doctors about managing their cardiovascular health. I know from experience that it's even hard to know the right questions to begin those conversations. You can start by asking: What changes can I make today? What can I do before my next appointment? What changes can I make to take care of my heart in the long term? How will I know if those changes are having an effect?

Everyone is different so its important to always work closely with your doctor on the treatment thats right for you. Go to KnowDiabetesbyHeart.org for a discussion guide you can print out and take with you, or bring it up on your phone at your appointment.

The site also has stories from people who are dealing with this issue. They are sharing their personal stories to encourage you, and to remind you, that you are not alone. There are even good recipes on the site to help with the dietary changes. Like many people, nutrition was particularly difficult for my mother when dealing with her diabetes. You eat what you like for so many years 65 years, for her and then you get this diagnosis and you think: Now I'm supposed to change. How? Where do I start? This is one way.

The other part of this is that non-Hispanic blacks, Hispanic Americans and Native Americans are at a significantly higher risk to develop Type 2 diabetes, which researchers think is a result of a combination of factors, including genetics, lifestyle factors, environmental factors and socioeconomic conditions.

Beyond that, we all know that, in this country, there is a great disparity in access to and quality of health care, which also plays out when it comes to Type 2 diabetes and its complications.

For instance, a 2017 study by the Centers for Disease Control and Prevention showed that, though the risk of eye disease among Type 2 diabetes patients is well known, African American and Latino Medicaid patients with Type 2 diabetes were significantly less likely to be offered eye exams than white patients. A 2007 study in Family Medicine showed that even if you control for access to health care and socioeconomic status, Latino patients with Type 2 diabetes were less likely than white patients to have foot exams from their doctors, even though the risk of damage to patients' extremities is well known.

That is why it is so important that everyone has access to information, resources and support, and that they know what questions to ask their doctors and how to follow up. Through Know Diabetes by Heart we want to show people living with Type 2 diabetes that theyve been diagnosed with a new purpose. Yes, you have Type 2 diabetes and, yes, you can manage it and live your amazing life.

As told to THINK editor Megan Carpentier, condensed and edited for clarity.

Angela Bassett is an Academy-award nominated actor, a director and an activist. She is currently serving as an ambassador for Know Diabetes by Heart, a joint initiative of the American Heart Association and the American Diabetes Association.

Go here to read the rest:
A Type 2 diabetes diagnosis can overwhelm you. But with the right information, you can go on. - NBC News

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Sinai Health System and University of Toronto, Toronto, Ontario, Canada (M.F.)

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (S.K.C., E.P., S.C.K.)

Financial Support: By the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Dr. Fralick received funding from the Eliot Phillipson Clinician-Scientist Training Program at the University of Toronto and the Canadian Institutes of Health Research through the Banting and Best PhD Award. Dr. Patorno is supported by a career development grant (K08AG055670) from the National Institute on Aging.

Disclosures: Dr. Patorno reports grants from the National Institute on Aging and Boehringer Ingelheim outside the submitted work. Dr. Kim reports grants from Pfizer, AbbVie, Roche, and Bristol-Myers Squibb outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at http://www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2610.

Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.

Reproducible Research Statement:Study protocol: Available from Dr. Fralick (e-mail, mike.fralick@mail.utoronto.ca). Statistical code: Not available. Data set: Available through IBM MarketScan (e-mail, watsonh@us.ibm.com).

Corresponding Author: Michael Fralick, MD, PhD, SM, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120; e-mail, mike.fralick@mail.utoronto.ca.

Current Author Addresses: Drs. Fralick, Chen, Patorno, and Kim: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120.

Author Contributions: Conception and design: M. Fralick, S.K. Chen, E. Patorno, S.C. Kim.

Analysis and interpretation of the data: M. Fralick, S.K. Chen, S.C. Kim.

Drafting of the article: M. Fralick, S.K. Chen.

Critical revision for important intellectual content: M. Fralick, S.K. Chen, E. Patorno, S.C. Kim.

Final approval of the article: M. Fralick, S.K. Chen, E. Patorno, S.C. Kim.

Statistical expertise: S.C. Kim.

Administrative, technical, or logistic support: M. Fralick, S.C. Kim.

Collection and assembly of data: M. Fralick.

Read the original:
Assessing the Risk for Gout With SGLT2 Inhibitors in Patients With Diabetes - Annals of Internal Medicine

Learn about addressing the emotional side of living with diabetes as part of comprehensive diabetes care.

Jeffrey Gonzalez, PhD, is a co-author of the Psychiatric and Psychosocial Issues among Individuals Living with Diabetes chapter in the NIDDK publication Diabetes in America, 3rd Edition. Here, he discusses how depression and diabetes distress affect people living with diabetes and what health care professionals can do to help their patients.

Q: Why should health care professionals be concerned about depression in patients who have diabetes?

A: Health care professionals should be aware that depression is more common in people with diabetes, and, when its present, its associated with poor health outcomes in people who have diabetes.

A 2001 meta-analysis suggested that depression could be about twice as common in people with diabetes as in people without diabetes, and that's similar to what's been found in other chronic illnesses. In 2008, some colleagues and I did a meta-analysis of the literature that found depression was consistently associated with poor diabetes self-management. Other meta-analyses have found consistent associations between depression and hyperglycemia, increased risks of diabetes complications, and even early mortality.

Q: What is diabetes distress and how is it related to depression?

A: In the medical field and in many conversations around feeling down or blue, we often use the concept, clinical depression. Thats partly because the Diagnostic and Statistical Manual of Mental Health highlights depression as a mental health disorder that can be diagnosed based on certain symptoms. However, its hard to draw the line between clinical depression and emotional reactions to stressful situations. Big events, such as loss of a loved one or loss of employment, can cause emotional responses and symptoms that are very similar to those of depression, at least over the short term.

One way that depression and diabetes distress are different is that diabetes distress is not thought of as a mental illness. Diabetes distress is a construct proposed by researchers to describe the emotional response to living with diabetes, a life-threatening illness that requires chronic, demanding, self-management. However, tools used to screen for diabetes distress dont ask only about emotions. They also ask about problems people have with their diabetes, such as a lack of social support, a poor relationship with their doctor, or difficulty accessing health care. Diabetes distress captures a persons experience with the problems associated with diabetes.

Diabetes distress is much more common than clinical depression among patients with diabetes. Recent literature reviews suggest that between 30 and 40 percent of adults with diabetes are likely to report significant levels of diabetes distress over time.

Q: How is diabetes distress related to diabetes treatment adherence and self-management?

A: A body of research shows that people who report more diabetes distress are also more likely to report more problems with self-management and medication adherence and may also have higher blood glucose levels. Some evidence suggests they may also be more likely to experience hypoglycemia and fear of hypoglycemia, which can affect their ability and willingness to take their medications

Diabetes distress and everyday diabetes management are closely linked, and its probably a two-way street. People feel stressed and have emotional responses such as feeling down or hopeless. Then, they may avoid dealing with their diabetes and experience setbacks, such as hypoglycemia, hyperglycemia, or complications. Those setbacks further contribute to their distress, and it can become a vicious cycle.

Q: Among people with diabetes, do some people have a higher risk for depression or diabetes distress than others?

A: Yes, some people with diabetes appear to have a higher risk.

Q: How can health care professionals address depression or distress in patients who have diabetes?

A: Addressing the emotional side of living with diabetes should be part of comprehensive diabetes care. Emotional distress of some kind is going to be more common in patients living with diabetes and may be caused by some of the stresses related to diabetes.

Providers can ask questions about how people are doing, how theyre feeling, and what aspects of their diabetes are causing stress. Providers can also acknowledge and normalize the idea that diabetes distress is common and could occur sometime in the course of the illness, perhaps with the onset of complications or with life changes that make following a diabetes self-management routine more difficult.

Diabetes distress can cause people to feel stuck and to benefit less from their diabetes treatments. Providers should look out for people experiencing diabetes distress and offer support by talking with patients about distress and encouraging them to think about ways to better manage their distress. Providers may also be able to make the diabetes treatment regimen less burdensome for the patient.

Its also important for providers to identify mental health professionals who can collaborate as part of the care team and provide more specialized help when its needed. Providers should think about how to help their patients find someone who can assist with depression or more significant problems with diabetes distress.

Q: Is there anything else that health care professionals should know about depression and diabetes distress in people with diabetes?

A: Depression and diabetes distress can be treated. We know about treatments for depression, from psychotherapy to pharmacological treatments. Diabetes distress seems to respond to many different kinds of interventions, including educational and supportive interventions.

A number of questionnaires are available to help providers screen for depression and diabetes distress in patients. As with any screening tool, the majority of people who screen positive wont actually have the disorder. Providers need to talk with patients after the screening to further evaluate what's going on. At times, providers may feel they need input from a mental health specialist to make that differential diagnosis and to recommend the most appropriate treatment.

Providers can find more information about screening and monitoring patients for depression and diabetes distress in Psychosocial Care for People with Diabetes: A Position Statement of the American Diabetes Association.

Q: What research is being conducted on the relationship between depression and diabetes?

A: More research in this area is needed. One area of current research is the dissemination and implementation of treatment models that we already know can be helpful.

For example, Im currently finishing a National Institutes of Health-supported trial that focuses on providing self-management support by telephone to adults with type 2 diabetes who are not at goal with their A1C. This program has been evaluated in a few previous trials, and we incorporated new components to train and support health educators in offering interventions that may be helpful for depression and diabetes distress.

Many studies are addressing how effective treatments can reach a wider number of people who need them, for example through interventions delivered by peers or community health workers. We have a mental health crisis in this country, where our mental health system does not meet the need among patients who are already identified. Screening programs that identify more people who need care will require a workforce and better reimbursements to meet that need. Over the next few years, well see more research on translating expert recommendations into care for depression and diabetes distress that can be replicated in many settings and sustained over time.

How do you address depression and diabetes distress in your patients with diabetes? Tell us below in the comments.

Read the rest here:
Diabetes Distress and Depression - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Starting this month, Chesprocott Health District will be offering a year-long program to prevent type 2 diabetes. The PreventT2 lifestyle change program offered by Chesprocott is a nationally recognized diabetes prevention program with proven results if participants join and finish the program.

Those who take part will learn how to eat healthy, add more physical activity to existing routines, manage stress, stay motivated, and solve problems that may get in the way of making changes. The meetings will be held in a group setting to provide a very supportive environment where one can learn coping skills that will help when dealing with the challenges of making changes to lifestyle.

The group will celebrate successes and find ways to overcome obstacles. The program will be presented by locally-trained lifestyle coaches. Participants will learn the skills needed to make lasting changes such as losing a modest amount of weight, being more physically active, and managing stress. The 12-month commitment works as such: weekly for the first six months, then once or twice a month for the second six months to maintain healthy lifestyle changes and needed support.

One in three American adults has prediabetes and doesnt know it, said Director of Health Maura Esposito. The PreventT2 program is not a new program. Its been around and proven to be effective. We decided to bring this to our residents as we have seen obesity increasing and lack of exercise has been identified as a need of this community.

Modest lifestyle changes made with the support of a coach and ones peers can have a lasting impression of improved health. People with prediabetes (higher-than-normal blood glucose) are five to 15 times more likely to develop type 2 diabetes than those with normal blood glucose levels. In fact, many people with prediabetes will be diagnosed with type 2 diabetes within five years.

If not managed, high blood sugar can lead to many health problems including: heart disease or a stroke; damaged kidneys that may require dialysis or a kidney replacement; eye blood vessels can be damaged, leading to blindness; blood circulation that doesnt work as well and wounds that dont heal as fast or become infected easier; sleep apnea; hearing problems; and increased risk for developing Alzheimers Disease.

There are too many health complications due to type 2 diabetes, so, if you think you are overweight, have been told by your doctor to lose weight and increase exercise, and want the support to make these changes, consider this program.

See the rest here:
Diabetes Prevention Program Being Offered In 2020 - Cheshire Herald

Coming to Billings on Saturday, February 1 at 10 a.m.

RSVP by January 25 at 406-366-1571

Led by a local Registered Dietitian and our in-store Pharmacist!

In just 90 minutes, enjoy an information-packed experience in your neighborhood grocery store and learn key information to inspire healthful food choices that will help you feel better and achieve better blood sugar levels. The dietitian will discuss the 3 steps to carb-counting success, how to create your diabetes-friendly plate, free foods shopping list, best options for meat/seafood and other important aisles of the store, portion size tips along with a mindful eating tasting exercise, and so much more! The stores pharmacist wraps up the tour with information about glucose meters, testing tips, recommended vaccinations, A1c testing and other health screenings, group classes, and other services available for individuals with diabetes and prediabetes. The tour is FREE but prior registration is required. Call Linda Allen at 406-366-1571 to reserve your spot. LIMITED SPACE AVAILABLE!

Here is the original post:
FREE Eating Healthy with Diabetes Grocery Store Tour - KULR-TV

The Diabetes Remission Clinical Trial (DiRECT), out of Newcastle University, UK, has shed a lot of light on our assumptions about the disease. The second year of research proved that type-2 diabetes is reversible, especially in patients that have had the disease for a short amount of time.

The treatment plan consists of a liquid diet of 800 calories to be taken as a soup or shake daily for a set number of months depending on how long its been since the patient developed type-2 diabetes. The course is a prescription for a reduction in calorie intake, which has already shown positive results for many other conditions.

Out of all the people taking part in the DiRECT trial, one-third were free of diabetes at two years. Around three-quarters of everyone who was in remission at one year stayed in remission at 2 years. Additionally, the group who embarked on rapid weight loss had fewer serious medical problems in the second year of the trial.

Further studies carried out by the trials lead Professors Mike Lean and Roy Taylor of Newcastle University showed that type-2 diabetes is triggered by fat spills. These fat spills, which came from the liver, travelled to the nearby pancreas where it wreaked havoc in the efficiency of the organ to produce insulin.

Insulin is needed to command your bodys cells to absorb excess carbohydrates circulating in your body after eating carbs or sugar-dense meal.

In April 2020, the NHS will begin trials with a liquid diet following the success of the DiRECT research. There are over 5,000 participants helping to test whether the program can benefit the public. If the trials are successful, the breakthrough diet will become the new standard of practice and treatment for the chronic disease thats been causing limb amputations, blindness, and heart complications for decades.

According to Diabetes UK, one in ten people over the age of 40 are suffering from type-2 diabetes in the UK.

Chris Askew, Chief Executive of Diabetes UK, said: Millions of type-2 diabetes cases could be prevented if we help people understand their risk and how to reduce it. Even though the older people get the more likely they are to have type-2 diabetes, it is never too early to know your risk so that you can make changes to prevent or delay it.

Recommended Related Articles

Read more from the original source:
Reversing type-2 diabetes with this new breakthrough treatment? - Health Europa

Home Topics Pediatric Endocrinology

The Food and Drug Administration (FDA) has approved Fiasp (insulin aspart injection; Novo Nordisk), a rapid-acting human insulin analog, for use in pediatric patients with diabetes mellitus.

The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes. Patients were randomized to either blinded mealtime Fiasp (injected 0 to 2 minutes before a meal; n=260), blinded mealtime NovoLog (injected 0 to 2 minutes before a meal; n=258), or open-label postmeal Fiasp (injected 20 minutes after the start of a meal; n=259), all in combination with once daily insulin degludec.

Findings showed that at Week 26, both mealtime and postmeal treatment with Fiasp resulted in effective glycemic control when compared with NovoLog. As for safety, hypoglycemia rates were found to be similar between the groups, however pediatric patients treated with Fiasp reported a higher rate of blood glucose confirmed hypoglycemic episodes, particularly during the nocturnal period.

Fiasp is available in multiple presentations including 10mL vials, 3mL FlexTouch pens, and 3mL PenFill cartridges for use in a PenFill cartridge delivery device. The treatment can be administered through subcutaneous injection, continuous subcutaneous infusion, or intravenous infusion.

Follow @EndoAdvisor

For more information visit novonordisk-us.com.

This article originally appeared on MPR

Please login or register first to view this content.

LoginRegister

Next post in Pediatric EndocrinologyClose

Excerpt from:
FDA Approves Mealtime Insulin Option for Pediatric Patients With Diabetes - Endocrinology Advisor

One symptom of type 2 diabetes you need to watch out for is blurred vision. This refers to the loss of sharpness and inability to see fine details. Diabetes UK report that one in three people will have complications with their eyes by the time theyre diagnosed with type 2 diabetes.

Blurred vision can happen in either one eye (unilateral) or both (bilateral) eyes, and is caused by high levels of blood sugar with those with type 2 diabetes (diagnosed or not) resulting in the lens inside the eye to swell.

Diabetes UK point out there are other common symptoms of diabetes people should be aware of:

If you notice blurred vision, it could indicate that you have diabetes that isnt controlled.

Persistent high blood sugar levels can damage the back of the eye (retina), medically known as diabetic retinopathy.

The retina needs a constant supply of blood to function, which it receives through a network of tiny blood vessels.

Over time, uncontrolled type 2 diabetes (signified by persistent high blood sugar levels) can damage the blood vessels servicing the retina.

READ MORE:How to lose visceral fat: Best oil to cook with if you want to reduce harmful belly fat

This happens in three main stages:

Background retinopathyBackground retinopathy is when tiny bulges develop in the blood vessels, which may bleed slightly but don't usually affect vision.

Pre-proliferative retinopathyPre-proliferative retinopathy is when more severe and widespread changes affect the blood vessels, including more significant bleeding into the eye.

Proliferative retinopathyProliferative retinopathy is when scar tissue and new blood vessels, which are weak and bleed easily, develop on the retina. This can result in some loss of vision

The NHS point out that it usually takes several years for diabetic retinopathy to reach a stage where it could threaten your sight, but it can cause blindness if left undiagnosed and untreated.

Anyone with type 2 diabetes is potentially at risk of developing diabetic retinopathy.

However, those with the highest chance of developing this complication of diabetes include those who:

The rest is here:
Type 2 diabetes symptoms: The sign in your eyes that could signal the condition - Express

The "Global Diabetes Insulin Delivery Pen Market Analysis, Trends, and Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.

The Global Diabetes Insulin Delivery Pen Market size is expected to exceed US$ 20 billion by 2026.

Highlighted with 14 tables and 268 figures, this 285-page report Global Diabetes Insulin Delivery Pen Market Analysis, Trends, and Forecasts to 2026 provides a comprehensive analysis of the fast-evolving, high-growth global diabetes insulin delivery pen market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global diabetes insulin delivery pen market. The report provides historical market data for 2013 - 2019, and forecasts from 2020 till 2026.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, insulin pen volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2026. It also provides an all-round analysis of an overall number of patients with diabetes and insulin users. A comprehensive analysis has been done on the market share of diabetes insulin delivery pen segment and countries-based market.

The report concludes with the profiles of major players in the global diabetes insulin delivery pen market. The key market players are evaluated on various parameters such as company overview, product portfolios and recent development of the global diabetes insulin delivery pen market.

Key Topics Covered in the Report:

The Report Helps Answer the Following Questions:

Key Topics Covered:

1. Executive Summary

2. Diabetes Insulin Delivery Pen Users (Volume), 2013 - 2026

2.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users (Volume), 2013 - 2026

2.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users (Volume), 2013 - 2026

3. Diabetes Insulin Delivery Pen Market Size & Analysis (Value), 2013 - 2026

3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market (Value), 2013 - 2026

3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market (Value), 2013 - 2026

4. Diabetes Insulin Delivery Pen Market Share, By Users (%), 2013 - 2026

4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2013 - 2026

4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2013 - 2026

5. Diabetes Insulin Delivery Pen Market Share, By Market Size (%), 2013 - 2026

5.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market Share (%), 2013 - 2026

5.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market Share (%), 2013 - 2026

6. Key Market Drivers & Inhibitors of the Diabetes Insulin Delivery Pen Market

6.1 Market Drivers

6.2 Market Inhibitors

7. Diabetes Insulin Delivery Pen Market & Forecast (2013 - 2026) - Major 16 Countries Data Analysis

7.1 United States

7.1.1 Overall Diabetes Population & Forecast (Volume)

7.1.2 Insulin Users & Forecast (Volume)

7.1.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)

7.1.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)

7.2 Canada

7.3 Germany

7.4 France

7.5 Italy

7.6 Spain

7.7 United Kingdom

7.8 Netherlands

7.9 Poland

7.10 Sweden

7.11 Turkey

7.12 Australia

7.13 Japan

7.14 China

7.15 India

7.16 Brazil

8. Key Companies Analysis

8.1 Novo Nordisk

8.1.1 Business Overview

8.1.2 Insulin Pen Products Portfolio

8.1.3 Recent Development

8.2 Eli Lilly

8.3 Sanofi

8.4 Owen Mumford

8.5 Ypsomed

8.6 Biocon Ltd.

8.7 Berlin-Chemie Ag (Haselmeier)

For more information about this report visit https://www.researchandmarkets.com/r/ukfe1o

View source version on businesswire.com: https://www.businesswire.com/news/home/20200113005377/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

See the original post:
The Global Diabetes Insulin Delivery Pen Market Size is Expected to Exceed US$ 20 Billion by 2026 - ResearchAndMarkets.com - Yahoo Finance

GREENVILLE A new year is a great time to take charge of your health with a free six-week Healthy U workshop for adults living with diabetes or pre-diabetes 2-4:30 p.m. on Fridays, Jan. 10 through Feb. 14 at Family Health (Conference Room), 5735 Meeker Road, Greenville. The workshop is open to adults of any age living with diabetes, pre-diabetes, and/or their caregivers, family, and friends.

Workshops need a minimum number of participants in order to take place. Register by calling Jane Urlage at (937) 547-2319, ext. 1229 or emailing jurlage@familyhealthservices.org. Sign up now to celebrate a healthier Valentines Day.

Healthy U is an evidence-based, interactive, small group workshop proven to improve quality of life and reduce health care expenses by increasing self-confidence and providing new skills to better manage symptoms and feel healthier. Participants explore new ways to address challenges common to anyone with diabetes. This workshop is different from clinical diabetes programs, and instead focuses on common problems like chronic pain, nutrition, exercise, medication use, emotions, and communicating with doctors and family. Participants develop skills and coping strategies to manage symptoms through setting achievable goals, problem-solving, decision-making, social support, and more.

Everyone who completes the course receives the companion textbook, Living a Healthy Life with Chronic Conditions, and a relaxation CD.

Workshops are supported by the Area Agency on Aging, PSA 2. The Agency on Aging helps older adults of west central Ohio remain in their homes with independence and dignity. We are an independent, private, nonprofit corporation that plans and funds services for older persons in Champaign, Clark, Darke, Greene, Logan, Miami, Montgomery, Preble, and Shelby Counties.

Follow this link:
New year is time to better manage diabetes - The Daily Advocate